Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 6, 2002, Pages 2021-2026

  Böcker Meffert, Simone ^a   Rosenstiel, Philip ^a   Röhl, Claudia ^a   Warneke, Nils ^a   Held Feindt, Janka ^a   Sievers, Jobst ^a   Lucius, Ralph ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ERYTHROPOIETIN; ETHOSUXIMIDE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; DOSE RESPONSE; EXPLANT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE FIBER GROWTH; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; RETINA GANGLION CELL; RETINA ISCHEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ERYTHROPOIETIN; ETHOSUXIMIDE; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; NERVE REGENERATION; NEURITES; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036275014     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production
2. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
3. Role of the kidney in erythropoiesis
4. Developmental changes in erythropoietin receptor expression of fetal mouse liver
5. Erythropoietin is present in the cerebrospinal fluid of neonates
6. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
7. Erythropoietin and erythropoietin receptor in the developing human central nervous system
8. Localization of specific erythropoietin binding sites in defined areas of the mouse brain
9. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
10. Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes
11. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
12. In vivo evidence that erythropoietin protects neurons from ischemic damage
13. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
14. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation
15. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated C57/BL mice through increasing nitric oxide production
16. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
17. Vascular endothelial growth rescues HN33 neural cells from death induced by serum withdrawal
18. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina
19. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor
20. Postnatal retinal ganglion cells in vitro: Protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes
21. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells
22. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats
23. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia
24. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
25. A qualitative comparison of the reactions of retinal ganglion cell axons to optic nerve crush in neonatal and adult mice
26. A quantitative comparison of the reactions of retinal ganglion cells to optic nerve crush in neonatal and adult mice
27. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
28. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death through PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo
29. Partial absorption of hard exudates in patients with diabetic endstage renal disease and severe anemia after treatment with erythropoietin
30. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
31. Recombinant human erythropoietin: Possible role as an antioxidant in premature rabbits
32. Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line
33. CAMs and axonal growth: A critical evaluation of the role of calcium and the MAPK cascade
34. CAMs and FGF cause a local submembrane calcium signal promoting axon outgrowth without a rise in bulk calcium concentration
35. Effects of erythropoietin on neuronal activity
36. The role of STATs in myeloid differentiation and leukemia
37. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines
38. Induction of erythroid proliferation and differentiation by a trophoblast-specific cytokine involves activation of the JAK/STAT pathway
39. YVAD protect post-natal retinal ganglion cells against axotomy-induced but not free radical-induced axonal generation in vitro
40. Ciliary neurotrophic factor and stress stimuli activate the Jak-STAT pathway in retinal neurons and glia
41. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
42. Enhanced proliferation, survival and dopaminergic differentiation of CNS precursors in lowered oxygen
43. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
44. Hypoxiainduced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
45. Identification of a neurotrophic sequence in erythropoietin